keyword
https://read.qxmd.com/read/38825658/advances-and-prospects-in-deuterium-metabolic-imaging-dmi-a-systematic-review-of-in-vivo-studies
#41
REVIEW
Feng Pan, Xinjie Liu, Jiayu Wan, Yusheng Guo, Peng Sun, Xiaoxiao Zhang, Jiazheng Wang, Qingjia Bao, Lian Yang
BACKGROUND: Deuterium metabolic imaging (DMI) has emerged as a promising non-invasive technique for studying metabolism in vivo. This review aims to summarize the current developments and discuss the futures in DMI technique in vivo. METHODS: A systematic literature review was conducted based on the PRISMA 2020 statement by two authors. Specific technical details and potential applications of DMI in vivo were summarized, including strategies of deuterated metabolites detection, deuterium-labeled tracers and corresponding metabolic pathways in vivo, potential clinical applications, routes of tracer administration, quantitative evaluations of metabolisms, and spatial resolution...
June 3, 2024: European Radiology Experimental
https://read.qxmd.com/read/38825108/transcriptional-responses-consistent-with-perturbation-in-dermo-epidermal-homeostasis-in-septic-sole-ulceration
#42
JOURNAL ARTICLE
T L Reeder, D S Zarlenga, A L Zeigler, R M Dyer
The aim of this study was to evaluate transcriptional changes in sole epidermis and dermis of bovine claws with septic sole ulceration of the lateral claw. Assessment included changes in transcripts orchestrating epidermal homeostatic processes including epidermal proliferation, differentiation, inflammation, and cell signaling. Sole epidermis and dermis was removed from region 4 of lesion-bearing lateral and lesion-free medial claws of pelvic limbs in multiparous, lactating Holstein cows. Control sole epidermis and dermis was obtained from region 4 of lateral claws of normal pelvic limbs...
May 31, 2024: Journal of Dairy Science
https://read.qxmd.com/read/38825017/glutaryl-coa-dehydrogenase-suppresses-tumor-progression-and-shapes-an-anti-tumor-microenvironment-in-hepatocellular-carcinoma
#43
JOURNAL ARTICLE
Yuanxiang Lao, Xiaohan Cui, Zhu Xu, Hongyao Yan, Zechuan Zhang, Zhenwei Zhang, Longpo Geng, Binghua Li, Yijun Lu, Qifei Guan, Xiaohong Pu, Suwen Zhao, Jiapeng Zhu, Xihu Qin, Beicheng Sun
BACKGROUND & AIMS: Crotonylation, a crotonyl-CoA-based non-enzymatic protein translational modification, affects diverse biological processes, such as spermatogenesis, tissue injury, inflammation, and neuropsychiatric diseases. Crotonylation shows decreased in hepatocellular carcinomas (HCCs), but the mechanism remains unknown. In this study, we aim to describe the role of glutaryl-CoA dehydrogenase (GCDH) in tumor suppression. METHODS: Three cohorts containing 40, 248 and 17 pairs of samples were used to evaluate the link between GCDH expression levels and the HCC clinical characteristics as well as anti-PD-1 response...
May 31, 2024: Journal of Hepatology
https://read.qxmd.com/read/38824833/peptides-derived-from-growth-factors-exploring-their-diverse-impact-from-antimicrobial-properties-to-neuroprotection
#44
REVIEW
Zhang Hai-Na, Jiang Jun-Jie, Xu Guang-Meng
Growth factor-derived peptides are bioactive molecules that play a crucial role in various physiological processes within the human body. Over the years, extensive research has revealed their diverse applications, ranging from antimicrobial properties to their potential in neuroprotection and treating various diseases. These peptides exhibit innate immune responses and have been found to possess potent antimicrobial properties against a wide range of pathogens. Growth factor-derived peptides have demonstrated the ability to promote neuronal survival, prevent cell death, and stimulate neural regeneration...
June 1, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38824752/antitumor-activity-and-safety-of-the-pd-1-inhibitor-retifanlimab-in-patients-with-recurrent-microsatellite-instability-high-or-deficient-mismatch-repair-endometrial-cancer-final-safety-and-efficacy-results-from-cohort-h-of-the-pod1um-101-phase-i-study
#45
JOURNAL ARTICLE
Dominique Berton, Patricia Pautier, Domenica Lorusso, Christine Gennigens, Laurence Gladieff, Anna Kryzhanivska, Jill Bowman, Chuan Tian, Mark Cornfeld, Toon Van Gorp
OBJECTIVE: Retifanlimab is a humanized immunoglobulin G4 monoclonal antibody against programmed death 1 being investigated in several solid tumor types. We report final results from patients with recurrent microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) endometrial cancer treated with retifanlimab in a POD1UM-101 expansion cohort. METHODS: Eligible patients (≥18 years; histologically proven/unresectable/recurrent, MSI-H/dMMR endometrial cancer; checkpoint inhibitor naive) received retifanlimab 500 mg intravenously every 4 weeks for ≤2 years...
June 1, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38824748/multi-mechanism-antitumor-antibacterial-effects-of-cu-egcg-self-assembling-nanocomposite-in-tumor-nanotherapy-and-drug-resistant-bacterial-wound-infections
#46
JOURNAL ARTICLE
Yinyin Chen, Haoran Li, Nana Liu, Dongju Feng, Wei Wu, Ke Gu, Aimin Wu, Chunxia Li, Xianxiang Wang
Chemotherapy and surgery stand as primary cancer treatments, yet the unique traits of the tumor microenvironment hinder their effectiveness. The natural compound epigallocatechin gallate (EGCG) possesses potent anti-tumor and antibacterial traits. However, the tumor's adaptability to chemotherapy due to its acidic pH and elevated glutathione (GSH) levels, coupled with the challenges posed by drug-resistant bacterial infections post-surgery, impede treatment outcomes. To address these challenges, researchers strive to explore innovative treatment strategies, such as multimodal combination therapy...
May 19, 2024: Journal of Colloid and Interface Science
https://read.qxmd.com/read/38824552/pi3k%C3%AE-inhibition-combined-with-dna-vaccination-unleashes-a-b-cell-dependent-antitumor-immunity-that-hampers-pancreatic-cancer
#47
JOURNAL ARTICLE
Claudia Curcio, Gianluca Mucciolo, Cecilia Roux, Silvia Brugiapaglia, Alessandro Scagliotti, Giorgia Guadagnin, Laura Conti, Dario Longo, Demis Grosso, Mauro Giulio Papotti, Emilio Hirsch, Paola Cappello, Judith A Varner, Francesco Novelli
Phosphoinositide-3-kinase γ (PI3Kγ) plays a critical role in pancreatic ductal adenocarcinoma (PDA) by driving the recruitment of myeloid-derived suppressor cells (MDSC) into tumor tissues, leading to tumor growth and metastasis. MDSC also impair the efficacy of immunotherapy. In this study we verify the hypothesis that MDSC targeting, via PI3Kγ inhibition, synergizes with α-enolase (ENO1) DNA vaccination in counteracting tumor growth.Mice that received ENO1 vaccination followed by PI3Kγ inhibition had significantly smaller tumors compared to those treated with ENO1 alone or the control group, and correlated with i) increased circulating anti-ENO1 specific IgG and IFNγ secretion by T cells, ii) increased tumor infiltration of CD8+ T cells and M1-like macrophages, as well as up-modulation of T cell activation and M1-like related transcripts, iii) decreased infiltration of Treg FoxP3+ T cells, endothelial cells and pericytes, and down-modulation of the stromal compartment and T cell exhaustion gene transcription, iv) reduction of mature and neo-formed vessels, v) increased follicular helper T cell activation and vi) increased "antigen spreading", as many other tumor-associated antigens were recognized by IgG2c "cytotoxic" antibodies...
June 1, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38823926/borate-bonds-containing-ph-responsive-chitosan-hydrogel-for-postoperative-tumor-recurrence-and-wound-infection-prevention
#48
JOURNAL ARTICLE
Yang Yu, Liang Zhang, Bin Hu, Zhengyue Wang, Qiuping Gu, Wenyi Wang, Chunping Zhu, Shige Wang
Chitosan has been widely used in biomedical fields due to its good antibacterial properties, excellent biocompatibility, and biodegradability. In this study, a pH-responsive and self-healing hydrogel was synthesized from 3-carboxyphenylboronic acid grafted with chitosan (CS-BA) and polyvinyl alcohol (PVA). The dynamic boronic ester bonds and intermolecular hydrogen bonds are responsible for the hydrogel formation. By changing the mass ratio of CS-BA and PVA, the tensile stress and compressive stress of hydrogel can controlled in the range of 0...
September 1, 2024: Carbohydrate Polymers
https://read.qxmd.com/read/38823383/gut-tumors-in-flies-alter-the-taste-valence-of-an-anti-tumorigenic-bitter-compound
#49
JOURNAL ARTICLE
Nicole Y Leung, Chiwei Xu, Joshua Shing Shun Li, Anindya Ganguly, Geoff T Meyerhof, Yannik Regimbald-Dumas, Elizabeth A Lane, David T Breault, Xi He, Norbert Perrimon, Craig Montell
The sense of taste is essential for survival, as it allows animals to distinguish between foods that are nutritious from those that are toxic. However, innate responses to different tastants can be modulated or even reversed under pathological conditions. Here, we examined whether and how the internal status of an animal impacts taste valence by using Drosophila models of hyperproliferation in the gut. In all three models where we expressed proliferation-inducing transgenes in intestinal stem cells (ISCs), hyperproliferation of ISCs caused a tumor-like phenotype in the gut...
May 29, 2024: Current Biology: CB
https://read.qxmd.com/read/38823264/identification-of-3-9h-carbazol-9-yl-2-1-3-dioxoisoindolin-2-yl-propanoic-acids-as-promising-dnmt1-inhibitors
#50
REVIEW
Jingyi Liu, Minli Ruan, Yueqin Liu, Xiaoqian Hong, Lijun Zhang, Qian Zhang
DNA methyltransferase 1 (DNMT1) is the primary enzyme responsible for maintaining DNA methylation patterns during cellular division, crucial for cancer development by suppressing tumor suppressor genes. In this study, we retained the phthalimide structure of N-phthaloyl-l-tryptophan (RG108) and substituted its indole ring with nitrogen-containing aromatic rings of varying sizes. We synthesized 3-(9H-carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acids and confirmed them as DNMT1 inhibitors through protein affinity testing, radiometric method using tritium labeled SAM, and MTT assay...
May 27, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38823180/auraptene-ameliorating-depressive-like-behaviors-induced-by-lipopolysaccharide-combined-with-chronic-unpredictable-mild-stress-in-mice-mitigate-hippocampal-neuroinflammation-mediated-by-microglia
#51
JOURNAL ARTICLE
Lu-Wen Zhang, Chun-Ai Cui, Chao Liu, Lian-Ping Sun, Yi-Nan Ouyang, Long-Fei Li, Dong-Liang Zhang, Hai-Ling Yu
An inflammatory response is one of the pathogeneses of depression. The anti-inflammatory and neuroprotective effects of auraptene have previously been confirmed. We established an inflammatory depression model by lipopolysaccharide (LPS) injection combined with unpredictable chronic mild stress (uCMS), aiming to explore the effects of auraptene on depressive-like behaviors in adult mice. Mice were divided into a control group, vehicle group, fluoxetine group, celecoxib group, and auraptene group. Then, behavioral tests were conducted to evaluate the effectiveness of auraptene in ameliorating depressive-like behavior...
May 31, 2024: International Immunopharmacology
https://read.qxmd.com/read/38823179/myricetin-ameliorates-the-severity-of-pancreatitis-in-mice-by-regulating-cathepsin-b-activity-and-inflammatory-cytokine-production
#52
JOURNAL ARTICLE
Ji-Won Choi, Joonyeon Shin, Ziqi Zhou, Ho-Joon Song, Gi-Sang Bae, Min Seuk Kim, Sung-Joo Park
Cathepsin B (CTSB) and inflammatory cytokines are critical in initiating and developing pancreatitis. Calcineurin, a central calcium (Ca2+ )-responsive signaling molecule, mediates acinar cell death and inflammatory responses leading to pancreatitis. However, the detailed mechanisms for regulating CTSB activity and inflammatory cytokine production are unknown. Myricetin (MC) exhibits various biological activities, including anti-inflammatory effects. Here, we aimed to investigate MC effects on pancreatitis and the underlying mechanisms...
May 31, 2024: International Immunopharmacology
https://read.qxmd.com/read/38822985/flavonoids-as-potential-therapeutics-against-neurodegenerative-disorders-unlocking-the-prospects
#53
REVIEW
Md Faysal, Zerrouki Dehbia, Mehrukh Zehravi, Sherouk Hussein Sweilam, M Akiful Haque, Kusuma Praveen Kumar, Rita D Chakole, Satish P Shelke, Swapna Sirikonda, Mohamed H Nafady, Sharuk L Khan, Firzan Nainu, Irfan Ahmad, Talha Bin Emran
Neurodegeneration, the decline of nerve cells in the brain, is a common feature of neurodegenerative disorders (NDDs). Oxidative stress, a key factor in NDDs such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease can lead to neuronal cell death, mitochondria impairment, excitotoxicity, and Ca2+ stress. Environmental factors compromising stress response lead to cell damage, necessitating novel therapeutics for preventing or treating brain disorders in older individuals and an aging population...
June 1, 2024: Neurochemical Research
https://read.qxmd.com/read/38821736/inhibition-of-nucleophosmin-b23-sensitizes-ovarian-cancer-cells-to-immune-check-point-blockade-via-pd-l1-in-ovarian-cancer
#54
JOURNAL ARTICLE
Chia-Lung Tsai, Yun-Hsin Tang, Lan-Yan Yang, Angel Chao, Chin-Jung Wang, Chiao-Yun Lin, Chyong-Huey Lai
BACKGROUND: Immune checkpoint inhibitors (ICIs) that against programmed cell death protein-1 (PD-1) and its ligand PD-L1 have been approved as a promising treatment of many human cancers. However, the responses to these ICIs were limited in patients with ovarian cancer. Studies have indicated that the response to PD-1/PD-L1 blockade might be correlated with the PD-L1 expression level in cancer cells. Nucleophosmin (NPM/B23) was found to be a potential target for immunotherapy. Whether NPM/B23 plays a role in cancer-associated immunity, such as PD-1/PD-L1 axis, and its underlying mechanisms remain largely unknown in ovarian cancer...
May 30, 2024: Journal of the Formosan Medical Association
https://read.qxmd.com/read/38821627/combination-treatment-of-biochanin-a-and-atorvastatin-alters-mitochondrial-bioenergetics-modulating-cell-metabolism-and-inducing-cell-cycle-arrest-in-pancreatic-cancer-cells
#55
JOURNAL ARTICLE
Vilas Desai, Satya Murthy Tadinada, Hoora Shaghaghi, Ross Summer, James C K Lai, Alok Bhushan
BACKGROUND/AIM: Pancreatic cancer is an aggressive type of cancer, with a dismally low survival rate of <5%. FDA-approved drugs like gemcitabine have shown little therapeutic success, prolonging survival by a mere six months. Isoflavones, such as biochanin A and daidzein, are known to exhibit anti-cancer activity, whereas statins reportedly have anti-proliferative effects. This study investigated the effects of combination treatment of biochanin A and atorvastatin on pancreatic cancer cells...
June 2024: Anticancer Research
https://read.qxmd.com/read/38821613/real-clinical-practice-of-combined-atezolizumab-plus-chemotherapy-in-patients-with-small-cell-lung-cancer
#56
JOURNAL ARTICLE
Satoshi Ano, Norihiro Kikuchi, Shinichiro Okauchi, Takeshi Numata, Ryota Nakamura, Toshihiro Shiozawa, Hiroko Watanabe, Tomohiro Tamura, Kunihiko Miyazaki, Shigen Hayashi, Takaaki Yamashita, Koichi Kurishima, Masaharu Inagaki, Takayuki Kaburagi, Takeo Endo, Hiroaki Satoh, Nobuyuki Hizawa
BACKGROUND/AIM: Atezolizumab, an anti-PD-L1 antibody, has been increasingly administered in combination with chemotherapy to patients with small cell lung cancer (SCLC). This study aimed to determine how patients with extensive disease (ED) -SCLC responded to atezolizumab with chemotherapy and found factors affecting long-term response and survival. PATIENTS AND METHODS: This study focused on patients with SCLC who were treated with a combination of atezolizumab and chemotherapy in Japan between 2019 and 2023...
June 2024: Anticancer Research
https://read.qxmd.com/read/38821061/tumor-cells-impair-immunological-synapse-formation-via-central-nervous-system-enriched-metabolite
#57
JOURNAL ARTICLE
Yihong Li, Min Huang, Minger Wang, Yi Wang, Peng Deng, Chunni Li, Jingying Huang, Hui Chen, Zhihao Wei, Qian Ouyang, Jinghua Zhao, Yiwen Lu, Shicheng Su
Tumors employ various strategies to evade immune surveillance. Central nervous system (CNS) has multiple features to restrain immune response. Whether tumors and CNS share similar programs of immunosuppression is elusive. Here, we analyze multi-omics data of tumors from HER2+ breast cancer patients receiving trastuzumab and anti-PD-L1 antibody and find that CNS-enriched N-acetyltransferase 8-like (NAT8L) and its metabolite N-acetylaspartate (NAA) are overexpressed in resistant tumors. In CNS, NAA is released during brain inflammation...
May 18, 2024: Cancer Cell
https://read.qxmd.com/read/38821052/deletion-of-the-mrna-endonuclease-regnase-1-promotes-nk-cell-anti-tumor-activity-via-oct2-dependent-transcription-of-ifng
#58
JOURNAL ARTICLE
Xin Sun, Yasuharu Nagahama, Shailendra Kumar Singh, Yuuki Kozakai, Hiroshi Nabeshima, Kiyoharu Fukushima, Hiroki Tanaka, Daisuke Motooka, Eriko Fukui, Eric Vivier, Diego Diez, Shizuo Akira
Limited infiltration and activity of natural killer (NK) and T cells within the tumor microenvironment (TME) correlate with poor immunotherapy responses. Here, we examined the role of the endonuclease Regnase-1 on NK cell anti-tumor activity. NK cell-specific deletion of Regnase-1 (Reg1ΔNK ) augmented cytolytic activity and interferon-gamma (IFN-γ) production in vitro and increased intra-tumoral accumulation of Reg1ΔNK -NK cells in vivo, reducing tumor growth dependent on IFN-γ...
May 24, 2024: Immunity
https://read.qxmd.com/read/38820964/vista-deficiency-exerts-anti-tumor-effects-in-breast-cancer-through-regulating-macrophage-polarization
#59
JOURNAL ARTICLE
Shasha Jin, Wanmei Liu, Xiaoyu He, Yuxin Zhang, Wenting Chen, Yinhao Wu, Jun Liu
Growing evidence had showed that tumor-associated macrophages (TAMs) have a tumor-promoting M2 phenotype which could drive pathological phenomena. In breast cancer, TAMs are abundantly present and may play an important role in the development of breast cancer. V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel inhibitory checkpoint and immunotherapy target for tumor through regulating immune response. However, its effects on macrophages have not been investigated, which was also the focus of this study...
May 30, 2024: International Immunopharmacology
https://read.qxmd.com/read/38820888/phase-ib-trial-of-irx-2-plus-durvalumab-in-patients-with-recurrent-and-or-metastatic-head-and-neck-squamous-cell-carcinoma
#60
JOURNAL ARTICLE
Robin Park, Jiannong Li, Robbert J C Slebos, Ritu Chaudhary, Maria I Poole, Carina Ferraris, Joaquim Farinhas, Juan Hernandez-Prera, Kedar Kirtane, Jamie K Teer, Xiaofei Song, MacLean S Hall, Jason Tasoulas, Antonio L Amelio, Christine H Chung
OBJECTIVES: IRX-2 is a multi-cytokine immune-activating agent with anti-tumor activity in non-metastatic head and neck squamous cell carcinoma (HNSCC). Here, we evaluated combined IRX-2 and durvalumab in patients with recurrent and/or metastatic HNSCC. MATERIALS AND METHODS: This was a phase Ib trial consisting of dose escalation and expansion. Primary endpoints were safety and biomarkers to assess the immune response in the tumor microenvironment including significant increases in PD-L1 expression and CD8 + tumor infiltrating lymphocytes (TIL) comparing pre- and on-treatment tumor biopsies...
May 30, 2024: Oral Oncology
keyword
keyword
13674
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.